CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.

Saved in:
Bibliographic Details
Title: CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.
Authors: Prieto S; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Dubra G; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Camasses A; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Aznar AB; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Begon-Pescia C; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France., Simboeck E; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Pirot N; IRCM, University of Montpellier, ICM, INSERM, Montpellier, France.; BioCampus, RHEM, University of Montpellier, CNRS, INSERM, Montpellier, France., Gerbe F; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France.; IGF, University of Montpellier, CNRS, Inserm, Montpellier, France., Angevin L; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Jay P; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France.; IGF, University of Montpellier, CNRS, Inserm, Montpellier, France., Krasinska L; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France., Fisher D; IGMM, University of Montpellier, CNRS, Inserm, Montpellier, France.; Equipe Labellisée LIGUE 2018, Ligue Nationale Contre le Cancer, Paris, France.
Source: EMBO reports [EMBO Rep] 2023 Feb 06; Vol. 24 (2), pp. e54261. Date of Electronic Publication: 2022 Dec 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1469-3178
DOI:10.15252/embr.202154261